Qingdao Vland Biotech INC. (SHA:603739)
China · Delayed Price · Currency is CNY 12.44
+0.22 (1.80%)
Jun 23, 2026, 3:00 PM CST
SHA:603739 Market Cap
SHA:603739 has a market cap or net worth of 3.09 billion as of June 23, 2026. Its market cap has decreased by -8.74% in one year.
Market Cap
3.09B
Enterprise Value
3.42B
Revenue
1.40B
Ranking
n/a
PE Ratio
39.63
Stock Price
12.44
Market Cap Chart
Since January 16, 2019, SHA:603739's market cap has increased from 2.27B to 3.09B, an increase of 36.27%. That is a compound annual growth rate of 4.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 3.15B | -12.08% |
| Dec 31, 2025 | 3.58B | 18.02% |
| Dec 31, 2024 | 3.03B | -21.22% |
| Dec 29, 2023 | 3.85B | 13.69% |
| Dec 30, 2022 | 3.39B | -27.76% |
| Dec 31, 2021 | 4.69B | 34.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 3.50B |
| Hefei Lifeon Pharmaceutical | 3.46B |
| Hinova Pharmaceuticals | 3.43B |
| Baolingbao Biology | 3.42B |
| Shanghai Obio Technology (Group) Corp. | 3.40B |
| Boji Medical Technology | 3.31B |
| Jiangsu Sihuan Bioengineering | 3.27B |
| Hubei Goto Biopharm Group | 3.12B |